Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Global Market Report 2024

The hepatic-pancreatic-biliary (HPB) surgical device market size has grown strongly in recent years. It will grow from $4.85 billion in 2023 to $5.25 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth experienced in the historical period can be credited to factors such as an aging population, the worldwide expansion of healthcare infrastructure, an increase in minimally invasive surgical procedures, regulatory authorizations and standardization, and a heightened demand for ambulatory surgical centers.

The hepatic-pancreatic-biliary (HPB) surgical device market size is expected to see strong growth in the next few years. It will grow to $6.83 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period can be ascribed to the escalating incidence of diseases related to the liver and pancreas, a surging prevalence of gallbladder issues in younger adults, the upswing in medical tourism, a heightened focus on maintaining a healthy diet, and the increasing prevalence of Hepatopancreatobiliary (HPB) disorders. Notable trends expected in the forecast period encompass the adoption of remote surgical platforms, the integration of nanotechnology in surgical devices, the development of patient-specific implants, the utilization of smart surgical instruments, and the incorporation of augmented reality (AR) in surgical planning.

The hepatic-pancreatic-biliary (HPB) surgical device market is poised for growth, fueled by the rise in medical tourism. This trend involves individuals traveling to other regions or countries to access specialized medical treatments and procedures. HPB surgical devices play a crucial role in providing these patients with advanced surgical solutions for liver, pancreas, and bile duct issues. Notably, in September 2022, ALM BenefitsPRO reported a significant increase in the number of Americans seeking medical care abroad, highlighting the growing preference for cost-effective, technologically advanced, and accessible healthcare options in foreign destinations.

Key players in the hepatic-pancreatic-biliary (HPB) surgical device market are focusing on innovative technological advancements to stay ahead in the competitive landscape. One notable innovation is the development of robotic-assisted surgical staplers, which enhance surgical precision and efficiency. These staplers are particularly valuable in various surgical procedures, including those involving gastrointestinal, surgical oncology, bariatric, and HPB surgeries. For instance, in June 2021, Intuitive Surgical Inc. introduced SureForm, a robotic-assisted surgical stapler featuring SmartFire technology. This integrated software automatically adjusts the firing process during stapling, ensuring optimal staple line consistency and minimizing tissue damage across different tissue thicknesses.

In December 2021, GE Healthcare Technologies, a renowned US-based medical technology giant, finalized the acquisition of Bk Medical Holding Company Inc. for $1.45 billion. This strategic acquisition was meticulously crafted to reinforce GE Healthcare's ultrasound division and expand its array of imaging services, with a particular focus on enhancing support for hepatic, pancreatic, and biliary (HPB) surgeries, along with other complex surgical procedures requiring advanced imaging solutions. Bk Medical Holding Company Inc., a distinguished US-based medical devices firm specializing in manufacturing HPB surgical devices, perfectly complements GE Healthcare's vision for advancing medical imaging technologies.

Major companies operating in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Cardinal Health Inc., Johnson & Johnson Services Ltd., General Electric Company, 3M Company, Medtronic Plc, KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, BD CooperSurgical Inc., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Smith & Nephew plc, Steris Plc, W.L. Gore & Associates Inc., Cook Medical Inc., CONMED Corporation, Richard Wolf GmbH, CooperSurgical Inc., Medi-Globe GmbH, Thompson Surgical Instruments Inc., Lotus Surgicals Pvt. Ltd., Comepa Industries, Hobbs Medical Inc., TeleMed Systems Inc., Medorah Meditek Pvt. Ltd., Origio India Pvt. Ltd.

North America was the largest region in the hepatic-pancreatic-biliary (HPB) surgical device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices are specialized instruments designed for cutting, dissecting, grasping, and suturing tissues in surgical procedures involving the liver (hepato-), pancreas (pancreatic-), and bile ducts (biliary). These devices play a crucial role in performing intricate procedures on these delicate organs.

The main products in the field of hepato-pancreatic-biliary (HPB) surgeries surgical devices include electrosurgery instruments, endoscopes, hand instruments, access instruments, stents, energy/vessel sealing devices, visualization and robotic surgical systems, surgical suture and stapler devices, and fluid management systems. Electrosurgery instruments utilize high-frequency, alternating electric current to generate heat in tissues, enabling various surgical procedures such as cutting, coagulating, desiccating, or fulgurating tissue. These devices find indications in the treatment of conditions such as liver cancer, pancreatic cancer, gallstones, bile duct cancer, cirrhosis, pancreatitis, and cholecystitis. They are commonly used in hospitals, specialty clinics, trauma centers, and ambulatory surgical centers.

The hepato-pancreatic-biliary (HPB) surgeries surgical devices market research report is one of a series of new reports that provides hepato-pancreatic-biliary (HPB) surgeries surgical devices market statistics, including hepato-pancreatic-biliary (HPB) surgeries surgical devices industry global market size, regional shares, competitors with hepato-pancreatic-biliary (HPB) surgeries surgical devices market share, detailed hepato-pancreatic-biliary (HPB) surgeries surgical devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hepato-pancreatic-biliary (HPB) surgeries surgical devices industry. This hepato-pancreatic-biliary (HPB) surgery surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hepato-pancreatico-biliary (HPB) surgeries surgical devices market includes revenues earned by entities by liver surgeries, ultrasonic aspirators, liver retractors, and liver transplantation treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepato-pancreatico-biliary (HPB) surgeries surgical devices market also includes sales of visualization and access instruments, trocars, energy devices, and ultrasonic scalpels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.